Cargando…
Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death that often goes undetected in the general population. HCM is also prevalent in patients with cardio-facio-cutaneous syndrome (CFCS), which is a genetic disorder characterized by aberrant signaling in the RAS/MAPK signaling...
Autores principales: | Cashman, Timothy J., Josowitz, Rebecca, Johnson, Bryce V., Gelb, Bruce D., Costa, Kevin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718533/ https://www.ncbi.nlm.nih.gov/pubmed/26784941 http://dx.doi.org/10.1371/journal.pone.0146697 |
Ejemplares similares
-
Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes
por: Josowitz, Rebecca, et al.
Publicado: (2016) -
Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression
por: Josowitz, Rebecca, et al.
Publicado: (2014) -
Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy
por: Verschure, Derk O., et al.
Publicado: (2015) -
Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy
por: Knight, Walter E., et al.
Publicado: (2021) -
Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy
por: Tolosana, José Maria, et al.
Publicado: (2018)